Some great information here. I have been buying at the low prices on the basis that the share price will move when rates fall. I guess the price will still improve but your comments are very relevant.
l have also consider REP delisting. I cannot see any negatives in that. Obviously that would be a real win for shareholders and least initially.
Any thoughts ?
- Forums
- ASX - By Stock
- REP
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-14
Featured News
Add REP (ASX) to my watchlist
(20min delay)
|
|||||
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $313.8M |
Open | High | Low | Value | Volume |
63.5¢ | 63.5¢ | 61.5¢ | $531.2K | 849.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 36598 | 61.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
64.5¢ | 20779 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 36598 | 0.615 |
3 | 65906 | 0.610 |
3 | 15000 | 0.600 |
1 | 1017 | 0.590 |
1 | 40000 | 0.585 |
Price($) | Vol. | No. |
---|---|---|
0.645 | 20779 | 1 |
0.655 | 35460 | 1 |
0.660 | 34075 | 1 |
0.670 | 30000 | 1 |
0.675 | 53477 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
REP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online